BACKGROUND: Recruitment of antigen-specific T(H)2 cells into the lung is critical for the development of allergic airway inflammation. Although CCR4 and CCR8 are preferentially expressed on T(H)2 cells and CCR4, CCR8, and CXCR3 ligands are increased in asthma, the specific relative contribution of these receptors to antigen-specific T(H)2 cell trafficking into the allergic lung is not known. OBJECTIVE: To determine the relative contribution of the chemokine receptors CCR4, CCR8, and CXCR3 to antigen-specific T(H)2 cell trafficking in a murine model of allergic pulmonary inflammation. METHODS: We used adoptive transfer experiments to compare the trafficking of wild-type antigen-specific T(H)2 cells with antigen-specific T(H)2 cells deficient in CCR4, CCR8, or CXCR3. RESULTS: CCR4-deficient antigen-specific T(H)2 cells failed to traffic efficiently into the lung and the airways. In contrast, CCR8-deficient antigen-specific T(H)2 cells accumulated in these sites. Trafficking of CXCR3-deficient antigen-specific T(H)2 cells and CCR4-deficient and CCR8-deficient antigen-specific T(H)1 cells were comparable to their wild-type counterparts. Approximately 60% of IL-4-producing antigen-specific T cells expressed CCR4. Disruption of CCR4-mediated antigen-specific T(H)2 cell trafficking decreased the levels of T(H)2-type cytokines in the airways and reduced airway eosinophilia and mucus production. CONCLUSIONS: Our study demonstrates that CCR4 is required for the efficient entry of antigen-specific T(H)2 cells into the lung and the airways in a murine model of allergic pulmonary inflammation.
BACKGROUND: Recruitment of antigen-specific T(H)2 cells into the lung is critical for the development of allergic airway inflammation. Although CCR4 and CCR8 are preferentially expressed on T(H)2 cells and CCR4, CCR8, and CXCR3 ligands are increased in asthma, the specific relative contribution of these receptors to antigen-specific T(H)2 cell trafficking into the allergic lung is not known. OBJECTIVE: To determine the relative contribution of the chemokine receptors CCR4, CCR8, and CXCR3 to antigen-specific T(H)2 cell trafficking in a murine model of allergic pulmonary inflammation. METHODS: We used adoptive transfer experiments to compare the trafficking of wild-type antigen-specific T(H)2 cells with antigen-specific T(H)2 cells deficient in CCR4, CCR8, or CXCR3. RESULTS:CCR4-deficient antigen-specific T(H)2 cells failed to traffic efficiently into the lung and the airways. In contrast, CCR8-deficient antigen-specific T(H)2 cells accumulated in these sites. Trafficking of CXCR3-deficient antigen-specific T(H)2 cells and CCR4-deficient and CCR8-deficient antigen-specific T(H)1 cells were comparable to their wild-type counterparts. Approximately 60% of IL-4-producing antigen-specific T cells expressed CCR4. Disruption of CCR4-mediated antigen-specific T(H)2 cell trafficking decreased the levels of T(H)2-type cytokines in the airways and reduced airway eosinophilia and mucus production. CONCLUSIONS: Our study demonstrates that CCR4 is required for the efficient entry of antigen-specific T(H)2 cells into the lung and the airways in a murine model of allergic pulmonary inflammation.
Authors: J J Campbell; C E Brightling; F A Symon; S Qin; K E Murphy; M Hodge; D P Andrew; L Wu; E C Butcher; A J Wardlaw Journal: J Immunol Date: 2001-02-15 Impact factor: 5.422
Authors: S Kawasaki; H Takizawa; H Yoneyama; T Nakayama; R Fujisawa; M Izumizaki; T Imai; O Yoshie; I Homma; K Yamamoto; K Matsushima Journal: J Immunol Date: 2001-02-01 Impact factor: 5.422
Authors: P Panina-Bordignon; A Papi; M Mariani; P Di Lucia; G Casoni; C Bellettato; C Buonsanti; D Miotto; C Mapp; A Villa; G Arrigoni; L M Fabbri; F Sinigaglia Journal: J Clin Invest Date: 2001-06 Impact factor: 14.808
Authors: Dolores M Conroy; Louise A Jopling; Clare M Lloyd; Martin R Hodge; David P Andrew; Timothy J Williams; James E Pease; Ian Sabroe Journal: J Leukoc Biol Date: 2003-07-15 Impact factor: 4.962
Authors: Y Chvatchko; A J Hoogewerf; A Meyer; S Alouani; P Juillard; R Buser; F Conquet; A E Proudfoot; T N Wells; C A Power Journal: J Exp Med Date: 2000-05-15 Impact factor: 14.307
Authors: S W Chensue; N W Lukacs; T Y Yang; X Shang; K A Frait; S L Kunkel; T Kung; M T Wiekowski; J A Hedrick; D N Cook; A Zingoni; S K Narula; A Zlotnik; F J Barrat; A O'Garra; M Napolitano; S A Lira Journal: J Exp Med Date: 2001-03-05 Impact factor: 14.307
Authors: A Iellem; M Mariani; R Lang; H Recalde; P Panina-Bordignon; F Sinigaglia; D D'Ambrosio Journal: J Exp Med Date: 2001-09-17 Impact factor: 14.307
Authors: Cyrille Mionnet; Vanessa Buatois; Akira Kanda; Valerie Milcent; Sebastien Fleury; David Lair; Marie Langelot; Yannick Lacoeuille; Edith Hessel; Robert Coffman; Antoine Magnan; David Dombrowicz; Nicolas Glaichenhaus; Valerie Julia Journal: Nat Med Date: 2010-10-31 Impact factor: 53.440
Authors: Matthew W Parsons; Li Li; Aaron M Wallace; Min Jung Lee; Howard R Katz; James M Fernandez; Shinobu Saijo; Yoichiro Iwakura; K Frank Austen; Yoshihide Kanaoka; Nora A Barrett Journal: J Immunol Date: 2014-01-22 Impact factor: 5.422
Authors: Ana Claudia Araujo-Pires; Andreia Espindola Vieira; Carolina Favaro Francisconi; Claudia Cristina Biguetti; Andrew Glowacki; Sayuri Yoshizawa; Ana Paula Campanelli; Ana Paula Favaro Trombone; Charles S Sfeir; Steven R Little; Gustavo Pompermaier Garlet Journal: J Bone Miner Res Date: 2015-03 Impact factor: 6.741
Authors: Felix Heymann; Linda Hammerich; Dunja Storch; Matthias Bartneck; Sebastian Huss; Vanessa Rüsseler; Nikolaus Gassler; Sergio A Lira; Tom Luedde; Christian Trautwein; Frank Tacke Journal: Hepatology Date: 2012-01-13 Impact factor: 17.425
Authors: Irma Tindemans; Anne van Schoonhoven; Alex KleinJan; Marjolein Jw de Bruijn; Melanie Lukkes; Menno van Nimwegen; Anouk van den Branden; Ingrid M Bergen; Odilia Bj Corneth; Wilfred Fj van IJcken; Ralph Stadhouders; Rudi W Hendriks Journal: J Clin Invest Date: 2020-07-01 Impact factor: 14.808
Authors: K Mutalithas; C Guillen; C Raport; R Kolbeck; D Soler; C E Brightling; I D Pavord; A J Wardlaw Journal: Clin Exp Allergy Date: 2010-04-28 Impact factor: 5.018